Genentech is a biotechnology company founded in 1976, known for its pioneering work in developing medicines for serious medical conditions. It specializes in creating treatments for diseases such as cancer, multiple sclerosis, and other serious illnesses. The company is recognized for its innovative research and development processes. In 2009, Genentech became a member of the Roche Group, a global healthcare company. This partnership has allowed Genentech to expand its reach and resources, enhancing its ability to bring new therapies to market. The company is headquartered in South San Francisco, California, and continues to be a leader in the biotechnology field.